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Abstract  
Participating in regular physical activity is encouraged following breast cancer (BC) 
treatment, except for those who have subsequently developed lymphoedema.  We 
designed a randomised controlled trial to investigate the effect of participating in a 
supervised, mixed-type, moderate-intensity exercise program among women with 
lymphoedema following breast cancer.  Women <76 years who had completed BC 
treatment at least six months prior and subsequently developed unilateral, upper-limb 
lymphoedema were randomly allocated to an intervention (n=16) or control (n=16) 
group. The intervention group (IG) participated in 20 supervised group exercise 
sessions over 12 weeks, while the control group (CG) was instructed to continue 
habitual activities. Lymphoedema status was assessed by bioimpedance spectroscopy 
(impedance ratio between limbs) and perometry (volume difference between limbs).  
Mean baseline measures were similar for the IG (1.13+0.15 and 337+307ml, 
respectively) and CG (1.13+0.15 and 377+416ml, respectively) and no changes were 
observed over time.  However, 2 women in the IG no longer had evidence of 
lymphoedema by study end.  Average attendance was over 70% of supervised sessions, 
and there were no withdrawals.  The results indicate that, at worst, exercise does not 
exacerbate secondary lymphoedema.  Women with secondary lymphoedema should be 
encouraged to be physically active, optimising their physical and psychosocial recovery. 
 
Keywords: Lymphoedema, breast cancer, physical activity 
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Introduction 
By 18-months post-surgery, at least 30% of Australian breast cancer survivors have had 
lymphoedema (Hayes et al, 2008); a debilitating, distressing condition (Tobin et al, 
1993), that impairs the performance of ordinary tasks (Carter, 1997; Mirolo et al, 1995), 
sets woman apart socially and is a constant reminder of the cancer (Petrek & Heelan, 
1998).  There is significant evidence demonstrating that participating in exercise during 
and following treatment for breast cancer is associated with improvements in 
psychosocial and physical outcomes (Courneya et al, 2002; Courneya, 2003; 
Friedenreich & Courneya, 1996; Hayes & Newman, 2006; Stevinson et al, 2004), and 
emerging evidence linking active lifestyles with improved survival (Abrahamson et al, 
2006; Holick et al, 2008; Holmes et al, 2005).  Women with lymphoedema have 
traditionally been excluded from participating in exercise for fear of exacerbating the 
condition.  However, recent findings suggest that sedentary lifestyles may increase risk 
of developing lymphoedema (Hayes et al, 2008).  Further, participating in regular 
exercise plays an important role in maintaining a healthy and stable body weight, and 
being overweight or obese are considered risk factors for developing lymphoedema 
(Edwards, 2000; Petrek, 2001).   
 
While there is a paucity of research regarding the role of exercise for women with 
lymphoedema, preliminary work demonstrates that participation in an exercise 
programme does not precipitate lymphoedema, nor does it exacerbate the condition 
(Ahmed et al, 2006; Harris & Niesen-Vertommen, 2000; Lane et al, 2005; McKenzie & 
Kalda, 2003).  Unfortunately, these studies are limited by the type of sample, 
lymphoedema measurement, duration of the exercise program and/or lack of long-term 
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follow-up.  The purpose of this project was to investigate, in a randomised controlled 
trial (RCT), the effect of participating in a supervised, mixed-type, moderate-intensity 
exercise program on lymphoedema status, among women with lymphoedema following 
breast cancer and acceptability of the program.   
 
Methods 
Subject group 
Women younger than 76 years, who had completed treatment for unilateral breast 
cancer at least six months prior, subsequently had unilateral, upper-limb lymphoedema 
diagnosed by a health professional, and were prepared to travel to the exercise clinic for 
12 weeks (if randomly allocated to the intervention group) were eligible.  Following 
ethical approval, study information packs (n=316) were distributed via lymphoedema-
treating specialists (221), the Lymphoedema Association of Queensland (80) and our 
own database (31).  Of those that responded (54% response rate), 27 women declined to 
participate and did not provide any patient or treatment information, 7 women were 
ineligible and 32 women were eligible and consented to participate.  The remaining 106 
women provided patient and treatment information but were unable to participate due to 
the intervention requirements.   
 
Study design 
This study was a single-blind, RCT of a specific exercise program.   All measures were 
assessed pre-intervention (time 1; T1), immediately post-intervention (time 2; T2) and 
at 12-weeks follow-up (Time 3; T3), and were conducted by the same assessor who was 
blinded to participant group allocation.  Participants were randomly allocated to the 
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intervention group (IG) or control group (CG) following T1.  Stratifying according to 
severity of lymphoedema was necessary, since 38% of the sample (n=12) lacked 
objective evidence of the condition (CG, n=6; IG, n=6), as defined by our diagnostic 
criteria, at T1.   
 
Intervention 
The intervention involved a 12-week, moderate-intensity, mixed-type exercise program, 
including aerobic- and resistance-exercise (Table 1), conducted by an exercise 
physiologist and physiotherapist.  Participants used the Borg’s revised rating of 
perceived exertion scale(Borg, 1982) to monitor aerobic-based exercise intensity, while 
the maximum number of repetitions successfully completed with a given resistance 
assessed resistance-based intensity.  Exercise progression occurred throughout the 12-
week intervention period and the program was designed to maximise exposure to 
various types of exercise in an attempt to develop ‘independent and capable exercisers’ 
by study end.  The prescriptive nature of the program progressed to levels that meet 
national physical activity guidelines(Australian Institute of Health and Welfare, 2004), 
and on completion of the intervention, participants were instructed to continue with 
their established exercise regime but were not monitored. 
 
Measures 
Lymphoedema was assessed via standard objective measures, specifically bioimpedance 
spectroscopy (BIS; SEAC SFB3, Impedimed, Brisbane, Australia) and perometery 
(Manual Perometer Type 350 S, Pero-System Messgeraete GMBH, Wuppertal, 
Germany).  Using BIS, the impedance of the extracellular fluid for each limb at a range 
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of frequencies was assessed using the manufacturer’s software, and the ratio of these 
values comparing the treated and untreated sides was calculated.  Lymphoedema was 
considered to be present when the impedance ratio was more than three standard 
deviations above normative data, taking into account the significant effect of limb 
dominance(Cornish et al, 2001).  Perometry involved inserting the upper-limb into a 
horizontally-oriented frame that emits two parallel arrays of infra-red light beams at 
right angles to each other.  By assuming an elliptical cross-section, volume of both 
limbs and the volume difference between the limbs were calculated.  Lymphoedema 
was deemed present when the volume of the treated side was at least 200ml more than 
the untreated side.  
 
We also recorded number of supervised sessions attended per participant as well as 
reasons given for periods of absence.  Qualitative comments regarding the program and 
lymphoedema status, provided by the women during exercise sessions were recorded.  
For both IG and CG, data were collected via self-report on patient and treatment 
characteristics (Table 2).  At T2 and T3, additional information on changes made to 
undergarments, compression garments and/or lymphoedema treatment was collected.  
Women also responded to prompts, such as ‘you may wish to tell us what having 
lymphoedema feels like, what do you think caused your lymphoedema, whether certain 
activities aggravate or improve your lymphoedema’ in the questionnaire.   
 
Statistical analysis 
Lymphoedema values as assessed by BIS (ratios) and perometry (volumes in ml) were 
approximately normal for the study group at each testing phase, as were change scores 
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between T1 and T2, and T1 and T3.  Therefore, means and standard deviations have 
been used with independent t-tests (two-tailed P<0.05) to determine statistical 
significance of observed changes.  Qualitative comments were examined to determine 
the presence of common themes or points of difference across respondents and phases.  
 
Results 
Group characteristics 
The patient and treatment characteristics of the study sample (n=32) were similar to 
those who were unable to participate (n=106), although the participants were more 
likely to have been diagnosed with breast cancer more than 5 years previously (Table 
2).  The IG and CG also reported comparable patient and treatment characteristics at 
baseline, with mean age approximately 60 years, about half reporting low levels of 
education and more than two-thirds being in a significant relationship, with children.  
Breast cancer was diagnosed more than 5 years ago for 70% of IG and CG, while about 
half of the CG but only one-third of the IG experienced lymphoedema for more than 5 
years.  Lymphoedema-treatment characteristics of the groups were similar, and 
comparable behaviours at baseline were also observed (data not shown).   
 
Lymphoedema 
There were no significant differences in lymphoedema status at baseline or changes 
between testing phases observed between the IG and CG.  Mean impedance ratios at T1 
were 1.13+0.15 for the IG and 1.13+0.15 for the CG, while mean changes in impedance 
ratios between T1 and T2 were -0.01+0.06 and -0.00+0.09, and between T1 and T3 
were 0.02+0.07 and 0.01+0.09 for the IG and CG, respectively (Table 3).  With 
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perometry, baseline volume difference for the IG and CG were 337+307ml and 
377+416ml, respectively.  Mean volume changes between testing phases were 
insignificant and ranged from 2ml (IG: T1-T3) to 43ml (CG: T1-T2) (Table 3).   
 
Bioimpedance spectroscopy 
Evaluation of individual lymphoedema status by BIS at each of the three testing phases 
demonstrated that 9 of 16 (56%) IG participants had measurable evidence of the 
condition at T1.  Two (13%) of these women showed clinical improvements, so that by 
T3, they no longer had measurable lymphoedema.  One IG participant experienced a 
significant increase in swelling throughout the study period (ratios/volumes = T1: 
1.16/689ml; T2: 1.47/923ml; T3: 2.25/1870ml).  This participant attended 50% of the 
group-supervised sessions (sessions 1-8, 10, 20), all at low to moderate intensity 
involving whole-body, aerobic-based exercise.  A prolonged or repeated upper 
respiratory tract infection was the reason for missed sessions, and her lymphoedema 
became worse midway through her illness period.  Since completion of the study, this 
participant continued to experience worsening lymphoedema that did not respond to 
treatment and was later diagnosed with recurrent disease (approximately 6 months after 
study end).  Due to these circumstances, her data were removed.  Importantly, no 
adverse changes to lymphoedema status were found in those who participated more 
completely and at higher intensities in the intervention.  In regards to the CG, 6 women 
(38%) had measurable evidence of the condition at T1 and T3; an additional woman had 
measurable evidence of lymphoedema at T2, however her ratio declined again to within 
‘normal’ by T3.  One of the 16 women (6%) in the CG showed a clinical decline in her 
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ratio over time, but continued to have measurable evidence of the condition by T3.  The 
remainder of the CG had relatively stable ratios over time. 
 
Perometry 
With perometry, 9 out of 15 (60%) and 8 out of 14 (57%) IG women had measurable 
evidence of lymphoedema at T1 and T3, respectively, while 9 out of 16 (56%) and 10 
out of 15 (67%) CG women had evidence of lymphoedema at T1 and T3, respectively.  
Fluctuations of more than 10% volume difference between the treated and untreated 
sides were observed for individuals in both groups, irrespective of lymphoedema status 
according to perometry criteria, and resulted in overall group declines of 6% in the IG 
and 5% in the CG. 
 
Study adherence 
The majority of women (88%) allocated to the IG participated in 70% or more of 
scheduled supervised exercise sessions.   The intervention was scheduled over winter, 
and missed sessions were mostly related to respiratory illnesses (n=10).  Other reasons 
included were having a skin lesion removed (n=1), having gynaecological-surgery (n=1) 
and work commitments (n=2).  As already noted, one participant missed 50% of 
supervised sessions.  All participants (n=32) participated in T1 and T2, while data were 
unavailable for 2 participants (one in the IG and one in the CG) at T3.  To ensure 
missing data did not contribute to results found, data analysis was repeated excluding 
these 2 participants and no differences in results were observed (data not shown).   
 
Qualitative data  
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Comments recorded on the self-reported questionnaire revealed one overarching 
concern:  lymphoedema impacts all facets of an individual’s life. Illustrative quotes 
are provided in Table 4.  The sense of grief and frustration expressed by many women 
was exacerbated by uncertainty about the likely outcome of lymphoedema treatment, 
conflicting advice from health professionals, and the perceived need to maintain 
vigilance about activities that might exacerbate the problem, despite lack of clear 
evidence to guide them.  In addition, more in-depth interactions with those in the IG 
provided us with insight into how their feelings about being active evolved, including 
their sense of greater well-being and the importance of the program being ‘supervised’.  
However, despite providing positive comments regarding exercise participation and 
lymphoedema, women in both groups also suggested that “in particular heavy or 
repetitive use” or “heavy lifting” “aggravates the arm”.  Finally, among the IG, the fear 
that exercise may adversely effect their lymphoedema and that change in arm symptoms 
are related to worsening lymphoedema status were also evident.  One-third of the IG (6 
women) became concerned during the intervention because their arm symptoms were 
changing and thought this was indicative of their lymphoedema progressing.  As a 
consequence, we conducted a re-assessment by BIS around week 6.  At that time, 5 of 
the 6 women showed clinical improvements, while the other woman showed no change.   
The results gave the women reassurance and confidence that their arms were not 
adversely changing.   
 
Discussion 
Use of the treated arm following breast cancer treatment and the potential to influence 
risk of developing lymphoedema is a topic with limited evidence driving clinical 
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recommendations.  While it seems sensible to be cautious regarding use of the treated 
side, it is pertinent to acknowledge that the ‘muscle pump’ is considered the primary 
mechanism for moving lymph throughout the body(Tortora, 1992), and participating in 
physical activity activates the muscle pump mechanism.  This single-blind, RCT sought 
to evaluate the effect of participating in a 12-week supervised-exercise program on 
lymphoedema status among women previously diagnosed with clinical lymphoedema 
following breast cancer. 
     
No group changes were observed in lymphoedema status over the study period, 
although two of nine IG women (22%) with clinical evidence (by BIS) at baseline no 
longer had evidence of the condition at T3.  These results support the notion that 
participation in exercise is safe for those with upper-limb lymphoedema, and that at 
worst, exercise does not exacerbate swelling.  The specific intervention involved both 
aerobic- and resistance-based exercise, that targeted large as well as small muscle 
groups, including those of the upper-limb, and was undertaken at moderate to high 
intensities.  No adverse changes on lymphoedema status have been reported by others 
who have also examined the effect of mixed-type exercise programs (aerobic- and 
resistance-based)(McKenzie & Kalda, 2003; Turner et al, 2004) or resistance-based 
exercise alone(Ahmed et al, 2006), set at moderate intensities.  These are important 
findings, since it is known that sedentary lifestyles are associated with being overweight 
and that both of these characteristics are independent risk factors for developing breast 
cancer(Cleveland, 2007; Friedenreich, 2001; Thune & Furberg, 2001), lymphoedema 
following breast cancer(Edwards, 2000; Hayes et al, 2005; Hayes et al, 2008; Petrek, 
2001), and reduced survival following breast cancer(Abrahamson et al, 2006; Holick et 
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al, 2008; Holmes et al, 2005).  Therefore, while exercise currently lacks an evidence 
base in support of managing lymphoedema, its indirect role in maintaining healthy 
lifestyles and body weight following breast cancer as well as minimising risk of 
recurrence and optimising survival should be not be overlooked.   
 
As noted earlier, lymphoedema for one participant in the intervention group adversely 
progressed.  However, this seemed unrelated to group allocation as her participation in 
the program was limited, and when she did participate, the program was at low-intensity 
and constituted whole-body exercise.  Throughout and beyond the study period, the 
participant was under medical review and was subsequently diagnosed with recurrence.  
Whether her progression of lymphoedema was coincidental with progression of disease 
or provided an early sign is unknown but potentially worthy of future consideration.    
 
The profound effects that lymphoedema may have on a woman life’s have been 
previously described(Thomas-MacLean et al, 2005).  Gross and fine motor skills can be 
affected(Rymal, 2001), impacting work, home and personal care functions, as well as 
recreational activities and social relationships(Passik & McDonald, 1998). Other 
physical symptoms may include feelings of discomfort, heaviness, pain, tenderness and 
aching, and reports of multiple associated symptoms are common(Moffatt et al, 2003). 
In addition to physical symptoms, psychological distress, depression and anxiety(Carter, 
1997) as well as changes in body image and self-image have been reported, with 
dressing concerns reflecting one practical issue (Woods, 1993). The women in this 
study have further confirmed that lymphoedema does not just affect the treated side or 
limb; it influences the whole body and it “affects some capacity of every day-to-day 
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activity”.  Further, having lymphoedema brings with it a degree of social isolation, as it 
is an “unknown condition to many” including health professionals, friends, family and 
acquaintances.   It is a condition that is “difficult to explain” but “visible to all”.  
Accepting and surviving a breast cancer diagnosis is one thing, but coming to terms 
with the pervasive impact and uncertain course of lymphoedema is another.  
 
While the fear associated with the risk of developing lymphoedema has been previously 
reported(Petrek & Heelan, 1998), the women in this study emphasised that those with 
lymphoedema continue to live with fear - fear that their lymphoedema may progress.  
Women with breast cancer receive mixed messages from health professionals and 
various resources about optimal use of their treated arm.  These inevitably contribute to 
the trepidation women have regarding participation in particular activities.  Further, the 
IG participants highlighted just how acutely aware women with lymphoedema are of 
how their lymphoedematous side feels and how capable they are of identifying changes 
in arm symptoms.  Changing arm symptoms led to unplanned assessment of 
lymphoedema status midway through the intervention for 6 participants.  When the 
women were asked to describe the changes as being ‘good’, ‘bad’ or ‘just different’, the 
consensus was ‘just different’; but the results demonstrated improved objective status.  
It seems plausible that the increase in physical activity levels were contributing to 
changes in lymph movement and/or load, and in turn, changes in arm symptoms. It was 
clear that had these women not been under supervision and assessment, these changes in 
arm symptoms would have led to withdrawal from their planned exercise. Other 
qualitative comments provided by the IG participants further highlighted the importance 
of the intervention being supervised.   
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Anecdotally, current practice encourages use of garments while exercising.  As this 
recommendation lacks an evidence base, we encouraged each IG participant to make 
this decision herself.  Three women (22%) chose to wear a garment while exercising.  
Similar to findings from others(Johansson et al, 2005), no relationship between garment 
use and change in lymphoedema status was identified.  While these results are 
preliminary and require replication, factors such as impairment of heat transfer 
mechanisms, reduced range of motion and discomfort associated with wearing garments 
should be considered by clinicians and patients when making decisions about garment 
use during exercise. 
 
The intervention was designed by a team experienced in both research and clinical 
practice and reflecting the disciplines of exercise physiology, physiotherapy and 
psychiatry.  The primary outcome, lymphoedema, was assessed using two objective 
measures, and data collection allowed for 3-month follow-up to determine potential 
longer-term effects.  Despite extensive recruitment strategies, only 32 eligible women 
participated in the study.   While the participants had similar personal, treatment and 
behavioral characteristics compared with those who were unable to participate (n=106), 
it is likely that an overall response bias exists.  Those who responded to our recruitment 
efforts were likely a more active (less than 10% of the entire study sample were 
sedentary at T1), educated and affluent group, with the time and/or resources to seek 
more effective mechanisms to treat and manage their lymphoedema.  Also, 38% of the 
sample lacked measurable evidence of lymphoedema at baseline. It is therefore 
plausible that the intervention effect (positive or negative) on lymphoedema status 
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would be more difficult to observe.  Nonetheless, this was a RCT, with the IG and CG 
participants similar in personal, treatment and behavioural characteristics at baseline, 
using a single researcher for assessment, blinded to participant group allocation.  As 
such, the results of this work contribute to the growing body of evidence that those with 
lymphoedema can safely participate in exercise and that precluding participation in 
exercise for this subgroup of breast cancer survivors removes a plausible mechanism by 
which significant improvements in quality and quantity of survival could be attained.   
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Table 1  Parameters of the exercise intervention  
Type:   
Weeks 1-2 Aerobic only (floor-based aerobic exercise to music and walking) 
Weeks 3-4 Aerobic (floor-based aerobic exercise to music, water-based aerobic 
exercise and walking) and water-based resistance exercises 
Weeks 5-8 Aerobic (mix of all types) and water-based and free-weight resistance 
exercises  
Weeks 9-12 Aerobic (mix of all types) and machine-weight resistance exercise 
Intensity:   
Weeks 1-4 Aerobic: low to moderate (RPEa: 3-5) 
Resistance: low (≈20 repetitions per exercise)  
Weeks 5-8 Aerobic: Moderate (RPEa: 4-6) 
Resistance: Moderate (last successfully completed repetition reached at 
approximately 15 repetitions per exercise) 
Weeks 9-12 Aerobic: Moderate to high (RPEa: 4-7) 
Resistance: Moderate to high (last successfully completed repetition 
reached at approximately 10 repetitions per exercise) 
Duration:   
Weeks 1-4 20-30 minutes/session 
Weeks 5-8 30-45 minutes/session 
Weeks 9-12 45+ minutes/session 
Frequency:   
Weeks 1-4 3 times per week (2 supervisedb)   
Weeks 5-8 4 times per week (2 supervisedb)   
 20
Weeks 9-12 At least 4 times per week (1 supervisedb)   
All sessions included upper and lower body stretches as part of the warm-up and cool-down 
periods 
a Rating of Perceived Exertion Scale; b Supervised sessions were group-based with a 
maximum of 10 women in any session 
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Table 2 Personal, demographic and clinical characteristics of non-participants and 
participants 
    Non-
participants 
Participants Participants 
Personal and treatment-related characteristics Control Intervention 
 n n n  n
Age (years) (mean+SD)  106 (60+1
0)  
32 (59+9) 16 (60+1
1) 
16 (59+7) 
 n (%)  n (%) n  (%) n (%) 
Children in care       
  Never  19 (18)  5 (16) 2 (12) 3 (19) 
  Children (unknown ages)  28 (26)  10 (31) 5 (31) 5 (3) 
  Children aged >14 years   51 (48)  14 (44) 8 (50) 6 (38) 
  Children aged < 14 years  8 (8)  3 (9) 1 (6) 2 (13) 
Educationa              
  Low  57 (54) 16 (50) 7 (44) 9 (56) 
  Moderate  33 (31)  9 (28) 5 (31) 4 (25) 
  High  16 (15)  7 (22) 4 (25) 3 (19) 
Marital status              
  Married/de facto  71 (67) 23 (72) 12 (75) 11 (69) 
  Single/widowed/divorced  35 (33)  9 (28) 4 (25) 5 (31) 
Treated side              
  Dominant  53 (50) 19 (59) 8 (50) 11 (69) 
  Non-dominant  53 (50)  13 (41) 8 (50) 5 (31) 
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    Non-
participants 
Participants Participants 
Personal and treatment-related characteristics Control Intervention 
Years since breast cancer treatment     
  6 months – 5 years  57 (54) 10 (31) 5 (31) 5 (31) 
  >5 years  49 (46) 22 (69) 11 (69) 11 (69) 
Adjuvant treatment (yes)              
  Chemotherapy 41 (39) 17 (53) 7 (44) 10 (63) 
  Radiotherapy 79 (75) 21 (66) 11 (69) 10 (63) 
  Hormone Therapy  51 (48) 14 (44) 8 (50) 6 (38) 
Extent of lymph node removal              
  All  30  (28) 10 (31)  6 (38) 4 (25) 
  1+  76  (72) 22 (69) 10 (63) 12 (75) 
Years since lymphoedema diagnosis       
  <1 year  18 (17) 3 (9) 2 (13) 1 (7) 
  1-5 years  47 (44) 15  (47) 6 (38) 9 (64) 
  >5 years  23 (24) 12  (38) 8 (50) 4 (29) 
Current lymphoedema treatment        
  Physiotherapy 13 (12) 4 (13) 2 (13) 2 (13) 
  Massage  44 (42)  13 (41) 5 (31) 8 (50) 
  Compression  27 (26) 9 (28) 4 (25) 5 (31) 
  Exercise 8 (8) 0 (0) 0 (0) 0 (0) 
  Lymphatic drainage 6 (6) 1 (3) 0 (0) 1 (7) 
  laser  6 (6) 3 (9) 3 (19) 0 (0) 
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    Non-
participants 
Participants Participants 
Personal and treatment-related characteristics Control Intervention 
  Other  4 (4) 1 (4) 1 (6) 0 (0) 
* p values not shown but all were greater than 0.10; a Education categories: Low education defined as no formal 
education through to Grade 10 high school, Moderate education defined as completing school (Grade 12) or a 
trade/apprenticeship, High education defined as any formal education beyond completing Grade 12 high school.   
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Table 3 Changes observed in lymphoedema between pre- and post- intervention and 
pre-intervention and 3-months follow-up  
   
Change between 
T1a and T2 b 
Change between 
T1 a and T3 c 
 
Measures of lymphoedema N Mean (SD) Mean (SD) P values
Bioimpedance spectroscopy (ratio)    
 Control Group 16 -.00 (.09) .01 (.09) 0.75
  Intervention Group  15 -.01 (.06) .02 (.07) 0.88
Perometry (volumes, ml)       
 Control Group 16 43 (97) 19 (73) 0.35
  Intervention Group  15 13 (81) 2 (71) 0.53
a  T1, pre-intervention; b  T2, post-intervention; c T3, three-month follow-up 
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Table 4  Prominent themes emerging from participant written or verbal comments (both 
intervention and control groups) 
Themes Illustrative quotes 
Pervasive impact of 
lymphoedema  
“..it [lymphoedema] affects some capacity of every day-to-day 
activity.” 
“Feel like my whole body is affected by this lymphoedema.” 
“I don’t like the way my arm seems to affect all extremities 
especially my left arm and my back.” 
“It just seems all the energy is gone at times and you really have 
to force yourself to do things.”  
Grief, loss and 
uncertainty 
“I have tried many things to help myself and try to control the 
swelling, the pain I am experiencing but nothing seems to help, 
or if it does, it’s only briefly. I only want relief from this 
swelling……At present I cannot come to terms with what has 
happened to my arm, because there are many things and reasons 
I hate about it.” 
Isolation/Social 
impact  
“..only talk to persons who may have had it [lymphoedema] – as 
it is difficult trying to explain.” 
“the need to wear a constrictive sleeve always prompts questions 
from people which I find difficult to answer.” 
“compression garment hard to hide so tend not to wear same.” 
Evolving feelings 
regarding exercise, 
including their sense 
“It [exercise] makes me feel like I am able to use it more.” 
“Sweeping seems to be a good exercise! Lifting grandchildren 
also a good exercise (not so good on the back!).  Inactivity can 
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of greater well-being exacerbate the lymphoedema.” 
“I felt the lymphoedema was more under control while I was 
participating in the supervised exercise sessions (I also felt fitter 
at the latter part of the 12 weeks).”  
“I never knew I was able to do so much.” 
HOWEVER, when asked what ‘aggravates your lymphoedema’ 
heavy or repetitive use and heavy lifting featured in responses (2 
in the IG, 2 in the CG).  
Importance of the 
program being 
‘supervised’ 
“Without having you to guide me, there is no way I would have 
ever done the things I’ve done as part of this program.” 
“You gave me the confidence to know what I and my arm can 
do.” 
“I would not have tried the things I’ve done if not for the study.  
I now feel capable of joining an aqua class.”  
“You’ve shown me what I can do rather then tell me what I 
shouldn’t do.” 
 
 
 
 
 
